A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/24/2009	US20090317474 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
12/24/2009	US20090317471 matrix contains drug (hypotensive agents, antidepressants, anticonvulsants), ionic non-gelling matrix polymer (cellulose acetetate phthalate), and pH modifier; free of gelling or swelling excipient
12/24/2009	US20090317470 Oramucosal Pharmaceutical Dosage Form
12/24/2009	US20090317466 Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine
12/24/2009	US20090317464 Methods and compositions for producing anti-androgenic effects
12/24/2009	US20090317463 Composition for oral use based on s-adenosylmethionine and a process for their preparation
12/24/2009	US20090317460 Solid dosage form
12/24/2009	US20090317457 Anti-inflammatory and wound healing effects of lymphoid thymosin b-4
12/24/2009	US20090317453 Transdermal and topical administration of drugs using basic permeation enhancers
12/24/2009	US20090317452 Transdermal patch
12/24/2009	US20090317451 Pressure-sensitive adhesive for skin surface and/or transdermal substance delivery
12/24/2009	US20090317450 Pharmacokinetics of iontophoretic sumatriptan administration
12/24/2009	US20090317440 Anti-mitotic anti-proliferative compounds
12/24/2009	US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes
12/24/2009	US20090317412 Induction of an immune response against streptococcus pneumoniae polyaccharides
12/24/2009	US20090317411 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
12/24/2009	US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/24/2009	US20090317405 Antibody and uses thereof
12/24/2009	US20090317403 Use of CSF-1 Inhibitors
12/24/2009	US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP)
12/24/2009	US20090317392 Method of diagnosing small cell lung cancer
12/24/2009	US20090317391 Cancer Related Genes (PTPE)
12/24/2009	US20090317388 Tl1a in treatment of disease
12/24/2009	US20090317385 Methods Using Immunomodulatory Compounds for Modulating Level of CD59
12/24/2009	US20090317383 Cancer treatment method
12/24/2009	US20090317380 Use of prion conversion modulating agents
12/24/2009	US20090317377 Therapy procedure for drug delivery for trigeminal pain
12/24/2009	US20090317372 Small molecules for the reduction of high blood glucose level
12/24/2009	US20090317363 Cytokine Derivatives
12/24/2009	US20090317361 Carba-nucleoside analogs for antiviral treatment
12/24/2009	US20090317360 Anti-viral inhibitors and methods of use
12/24/2009	US20090317359 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase
12/24/2009	US20090317357 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents
12/24/2009	US20090317355 Abuse resistant melt extruded formulation having reduced alcohol interaction
12/24/2009	US20090317354 Composition for restoring damaged skin comprising a saccaride and povidone-iodine
12/24/2009	US20090317353 Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
12/24/2009	US20090317352 Hyperphosphatemia in domestic animals: compositions and methods of treatment
12/24/2009	US20090317343 Personal Care Compositions Containing Silicone Elastomer Gels
12/24/2009	US20090317341 Compositions for Lightening Skin Color
12/24/2009	US20090317337 Aerosol formulation for inhalation containing an anticholinergic agent
12/24/2009	US20090317331 Method of Identifying Partial Agonists of the A2A Receptor
12/24/2009	DE202008015430U1 Zusammensetzung zur Behandlung von Verdauungsstörungen Composition for the treatment of digestive disorders
12/24/2009	DE10262084B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage
12/24/2009	DE102008029734A1 Thiazolyl-piperidinderivate Thiazolyl-piperidine derivatives
12/24/2009	DE102008028905A1 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate 3- (3-pyrimidin-2-yl-benzyl) - [1,2,4] triazolo [4,3-b] pyridazine derivatives
12/24/2009	DE102008027868A1 Substance, useful to produce composition or medicament to treat otological disorders, preferably tinnitus and hearing disorders, comprises mixture of Chenopodium, quinine, acetylsalicylic acid and Conium maculatum in homeopathic dilution
12/23/2009	WO2009155611A1 Compositions for the treatment of fibrotic diseases or conditions
12/23/2009	WO2009155606A1 Anticancer compounds and methods of making and using same
12/23/2009	WO2009155585A1 N utragenomics
12/23/2009	WO2009155565A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009	WO2009155551A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009	WO2009155535A2 Compositions, methods and kits for eliciting an immune response
12/23/2009	WO2009155527A2 Phosphatidylinositol 3 kinase inhibitors
12/23/2009	WO2009155504A2 Methods for the modulation of angiogenesis
12/23/2009	WO2009155488A2 Novel oxalate salt and crystal of o-desmethylvenlafaxine
12/23/2009	WO2009155475A1 Paediatric compositions for treating1 multiple sclerosis
12/23/2009	WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/23/2009	WO2009155439A2 Use of nitrated lipids for treatment of side effects of toxic medical therapies
12/23/2009	WO2009155421A1 Gacyclidine formulations
12/23/2009	WO2009155413A1 Thienyl- and furanyl-isoquinolinones and methods for using them
12/23/2009	WO2009155402A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
12/23/2009	WO2009155401A1 Formulations
12/23/2009	WO2009155399A1 1-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/23/2009	WO2009155389A1 Triazolopyridine compounds useful as kinase inhibitors
12/23/2009	WO2009155388A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
12/23/2009	WO2009155379A2 Artemisinin and derivatives thereof as antivirals
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009155335A2 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
12/23/2009	WO2009155321A1 Pharmaceutical formulations for iontophoretic delivery of gallium
12/23/2009	WO2009155309A1 Substituted cyanopyrrolidine derivatives
12/23/2009	WO2009155156A1 Inhibitors of janus kinases
12/23/2009	WO2009155139A1 Use of isoindoles for the treatment of neurobehavioral disorders
12/23/2009	WO2009155135A1 Composition comprising liposome-entrapped doxorubicin and methods of admnistration for treatment of multiple myeloma
12/23/2009	WO2009155121A2 Inhibitors of pi3 kinase
12/23/2009	WO2009155118A1 Compositions and methods for inactivation of pathogens at genital tract surfaces
12/23/2009	WO2009155116A2 Methods of reducing pain and inflammation
12/23/2009	WO2009155100A1 Targeted oligonucleotide compositions for modifying gene expression
12/23/2009	WO2009155095A2 Methods to control qoi-resistant fungal pathogens
12/23/2009	WO2009155070A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions
12/23/2009	WO2009155069A1 Compositions and methods for treating psychiatric and neurodegenerative disorders
12/23/2009	WO2009155056A2 Non-hormonal steroid modulators of nf-kb for treatment of disease
12/23/2009	WO2009155054A2 5-ht3 receptor modulators, methods of making, and use thereof
12/23/2009	WO2009155052A1 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/23/2009	WO2009155042A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/23/2009	WO2009155041A2 Method to modulate hematopoietic stem cell growth
12/23/2009	WO2009155025A1 Methods of treating a meiotic kinesin-associated disease
12/23/2009	WO2009155024A1 Novel substituted indoles
12/23/2009	WO2009155017A2 Novel substituted azabenzoxazoles
12/23/2009	WO2009154963A1 Composition for therapy and imaging of cancer and associated methods
12/23/2009	WO2009154944A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
12/23/2009	WO2009154873A2 Use of novel lipid mediators to inhibit angiogenesis
12/23/2009	WO2009154870A1 Hiv integrase inhibitors
12/23/2009	WO2009154835A2 Compositions and methods related to mir-16 and therapy of prostate cancer
12/23/2009	WO2009154828A2 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
12/23/2009	WO2009154819A2 Treatment of inflammatory conditions and diseases with metal-thiols
12/23/2009	WO2009154810A2 Delivery systems for multiple active agents
12/23/2009	WO2009154800A2 Compositions and methods for treating lung disorders
12/23/2009	WO2009154785A2 C4-substituted alpha-keto oxazoles
12/23/2009	WO2009154782A1 Process for purifying rasagiline base
12/23/2009	WO2009154780A1 S1p1 receptor agonists and use thereof

1 ... 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 ... 7860